Oral antiplatelet agents (OAA) including aspirin and a P2Y12 inhibitor (such as clopidogrel) can prevent myocardial infarction (MI), stroke, and death in cardiovascular disease (Antithrom botic Trialists and Collaboration, 2002). The gene discussed is P2RY12; the disease is myocardial infarction.